NewAmsterdam Pharma Company N.V. Made Headway
Thu, Dec 15, 2022 at 06:58 PM
NewAmsterdam Pharma Company N.V. (NAMS:NASDAQ) jumped higher at $12, a gain of 27.7%. On Thu, Dec 15, 2022, NAMS:NASDAQ hit a New 2-Week High of $12. The stock got featured on our News Catalysts scanner on Fri, Nov 25, 2022 at 06:43 AM in the 'BIOTECH' category. From Thu, Dec 01, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days
About NewAmsterdam Pharma Company N.V. (NAMS:NASDAQ)
NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.
Top 10 Gainers:
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- Core Scientific Inc Cl A (CORZ:NASDAQ), 72%
- IMV Inc. (IMV:NASDAQ), 66.55%
- Creatd Inc. (CRTD:NASDAQ), 57.76%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 44.85%
- BeyondSpring Inc. (BYSI:NASDAQ), 33.04%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 31.13%
- Nuvve Holding Corp. (NVVE:NASDAQ), 31.05%
- Landos Biopharma Inc. (LABP:NASDAQ), 30.46%
- NewAmsterdam Pharma Company N.V. (NAMS:NASDAQ), 27.66%